ATE208400T1 - Pro-medikamente für cck-antagonisten - Google Patents

Pro-medikamente für cck-antagonisten

Info

Publication number
ATE208400T1
ATE208400T1 AT91918120T AT91918120T ATE208400T1 AT E208400 T1 ATE208400 T1 AT E208400T1 AT 91918120 T AT91918120 T AT 91918120T AT 91918120 T AT91918120 T AT 91918120T AT E208400 T1 ATE208400 T1 AT E208400T1
Authority
AT
Austria
Prior art keywords
pro
agents
useful
drugs
treatment
Prior art date
Application number
AT91918120T
Other languages
English (en)
Inventor
David Christopher Horwell
Martyn Clive Pritchard
Reginald Stewart Richardson
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/726,653 external-priority patent/US5340825A/en
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of ATE208400T1 publication Critical patent/ATE208400T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/021—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT91918120T 1990-08-31 1991-08-29 Pro-medikamente für cck-antagonisten ATE208400T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US57631590A 1990-08-31 1990-08-31
US07/726,653 US5340825A (en) 1990-08-31 1991-07-12 Pro drugs for CCK antagonists
PCT/US1991/006178 WO1992004038A1 (en) 1990-08-31 1991-08-29 Pro-drugs for cck antagonists

Publications (1)

Publication Number Publication Date
ATE208400T1 true ATE208400T1 (de) 2001-11-15

Family

ID=27076930

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91918120T ATE208400T1 (de) 1990-08-31 1991-08-29 Pro-medikamente für cck-antagonisten

Country Status (14)

Country Link
US (2) US5554643A (de)
EP (1) EP0546108B1 (de)
JP (1) JP3356431B2 (de)
AT (1) ATE208400T1 (de)
AU (1) AU649077B2 (de)
CA (1) CA2088980C (de)
DE (1) DE69132805T2 (de)
DK (1) DK0546108T3 (de)
ES (1) ES2167312T3 (de)
IE (1) IE913079A1 (de)
NO (1) NO300324B1 (de)
NZ (1) NZ239591A (de)
PT (1) PT98831B (de)
WO (1) WO1992004038A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2088980C (en) * 1990-08-31 2002-04-16 David C. Horwell Pro-drugs for cck antagonists
CA2110986A1 (en) * 1991-07-12 1993-01-21 Geoffrey Neil Woodruff Cholecystokinin antagonists useful in the treatment of panic attacks
US5217957A (en) * 1991-08-20 1993-06-08 Warner-Lambert Company Cholecystokinin antagonists useful for treating depression
US5380872A (en) * 1992-07-14 1995-01-10 Glaxo Inc. Modulators of cholecystokinin
CA2140640A1 (en) * 1992-08-13 1994-03-03 David C. Horwell Tachykinin antagonists
JP3419539B2 (ja) 1993-02-17 2003-06-23 中外製薬株式会社 インドリン−２−オン誘導体
US6869957B1 (en) 1993-11-17 2005-03-22 Eli Lilly And Company Non-peptide tachykinin receptor antagonists
US6403577B1 (en) 1993-11-17 2002-06-11 Eli Lilly And Company Hexamethyleneiminyl tachykinin receptor antagonists
US6129685A (en) * 1994-02-09 2000-10-10 The University Of Iowa Research Foundation Stereotactic hypothalamic obesity probe
US7077822B1 (en) 1994-02-09 2006-07-18 The University Of Iowa Research Foundation Stereotactic hypothalamic obesity probe
CA2152765A1 (en) 1994-06-30 1995-12-31 Jeroen Elisabeth-Joseph Knops Methods for treating a physiological disorder associated with beta amyloid peptide
US7109326B2 (en) * 1997-04-15 2006-09-19 Genentech, Inc. Halo-alkoxycarbonyl prodrugs
WO2008031221A1 (en) 2006-09-12 2008-03-20 Cephalin Pharmaceuticals Inc. Isovaline for treatment of pain
US10752589B2 (en) 2016-03-14 2020-08-25 Sphaera Pharma Pvt. Ltd. Trigonelline based compounds
US20200109117A1 (en) * 2018-10-02 2020-04-09 ACCESS Association Modified Therapeutic Agent Analogs of Mefenamic Acid

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2364659A1 (fr) * 1976-09-21 1978-04-14 Commissariat Energie Atomique Medicament antagoniste de l'action de la gastrine et des polypeptides apparentes
US4757151A (en) * 1985-11-14 1988-07-12 Warner-Lambert Company 2-substituted-[2-substituted-amino]-N-arylalkyl-3-[indol-3-yl]
JPH03503650A (ja) * 1988-04-05 1991-08-15 アボツト・ラボラトリーズ Ｃｃｋアンタゴニストとしてのトリプトファン誘導体
US4997950A (en) * 1989-04-20 1991-03-05 Richard Finbar Murphy Novel C-terminal gastrin antagonists
NZ234264A (en) * 1989-06-29 1993-05-26 Warner Lambert Co N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe- and phenethylamine derivatives, and pharmaceutical compositions
US5278316A (en) * 1989-06-29 1994-01-11 Warner-Lambert Company N-substituted cycloalkyl and polycycloalkyl alpha-substituted Trp-Phe- and phenethylamine derivatives
CA2088980C (en) * 1990-08-31 2002-04-16 David C. Horwell Pro-drugs for cck antagonists

Also Published As

Publication number Publication date
EP0546108A1 (de) 1993-06-16
US5554643A (en) 1996-09-10
NO930710D0 (no) 1993-02-26
EP0546108B1 (de) 2001-11-07
NZ239591A (en) 1994-07-26
AU649077B2 (en) 1994-05-12
ES2167312T3 (es) 2002-05-16
EP0546108A4 (en) 1993-09-22
NO300324B1 (no) 1997-05-12
NO930710L (no) 1993-04-21
JP3356431B2 (ja) 2002-12-16
US5726200A (en) 1998-03-10
DE69132805T2 (de) 2002-10-24
JPH06501007A (ja) 1994-01-27
IE913079A1 (en) 1992-03-11
AU8725091A (en) 1992-03-30
PT98831B (pt) 1999-02-26
CA2088980C (en) 2002-04-16
CA2088980A1 (en) 1992-03-01
DK0546108T3 (da) 2002-02-18
PT98831A (pt) 1992-08-31
DE69132805D1 (de) 2001-12-13
WO1992004038A1 (en) 1992-03-19

Similar Documents

Publication Publication Date Title
FI916060A0 (fi) Foerfarande foer framstaellning av n-substituerade cykloalkyl- och polycykloalkyl-a-substituerade trp-phe- och fenetylaminderivat.
DK0546108T3 (da) Pro-drugs for CCK-antagonister
KR100929363B1 (ko) 벤질리덴아미노구아니딘 및 히드록시구아니딘의멜라노코르틴 수용체 리간드로서의 용도
DK0975595T3 (da) Kokainanaloger
TW461878B (en) IL-8 receptor antagonists
MY123642A (en) Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, and processes for preparing them.
CA2417897A1 (en) Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
RU2005134230A (ru) Ацилированные производные спиропиперидина как агонисты рецептора меланокортина-4
EP0303465A3 (de) Phenethanolamin-Derivate
KR920006316A (ko) 칼슘 흡수 억제제
KR930700451A (ko) 항암제로서의 비스-나프탈이미드
WO2000055162A3 (en) Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
DE2808111A1 (de) Neue dipeptidderivate und deren verwendung zur messung der enzymatischen aktivitaet
DE69208569T2 (de) Thioharnstoffderivate und sie enthaltendes, antimikrobielles und antiulcerogenes Mittel
DE69810629T2 (de) Beta-alkoxyacrylate gegen malaria
JP2000256326A (ja) アルカロイド系化合物を含んでなるσレセプター作用薬
ES2126577T3 (es) Analogos alquilidenicos de 1'-aminoespiro(isoquinolino-4(1h),3'-pirrolidino)-1,2',3,5'(2h)-tetronas utiles como inhibidores de la aldosa reductasa in vivo.
ZA903944B (en) Pyrrolidone derivatives the process for their preparation and the pharmaceutical compositions containing them
YU3701A (sh) Supstituisani fenilamidini sa antitrombskim dejstvom
SU1742725A1 (ru) Способ прогнозировани течени звенной болезни
EP0308159A3 (de) Substituierte Pyridine als Dopamin-beta-hydroxylase-Inhibitoren
CN117440811A (zh) 用于治疗与核糖体障碍相关的贫血的组合物和方法
WO1994022413A2 (en) Triazole substituted quinoline derivatives
KR910000642A (ko) 인돌 유도체 및 이의 제조방법
JP2001527076A (ja) 海綿動物から単離されるアスマリンａ及びｂを含む細胞毒性アルカロイド誘導体

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee